Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based antibody designer says will help it accelerate its research and product development, as well ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.

Now, the Lundquist Institute (TLI) and Vitalex Biosciences announce that they will move forward in the development of the second-generation fungal vaccine candidate known as VXV‑01—up to and including ...

A new method uses the auxin-inducible degron (AID) system to tune protein levels with precision in living C. elegans.

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

The hydrogel preservation technology maintains cell viability for days at room temperature, removing cold-chain constraints.

Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.

Results open the door to therapies based on chronobiology, the branch of biology that studies how living organisms structure their physiological processes in time.

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Cosmo Pharmaceuticals attracted welcome attention from investors and other market watchers after coming out with topline ...